{"url_path":"/sec/bgms/10-q/2026/item-7","section_key":"item-7","section_title":"Item 7 , of our Annual Report on Form 10-K for the year ended December 31, 2025 and Note 2 to our unaudited consolidated financial statements","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1130166/0001493152-26-023800-index.html","accession_number":"0001493152-26-023800","cik":"0001130166","ticker":"BGMS","issuer_name":"Bio Green Med Solution, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1130166/0001493152-26-023800-index.html","primary_entity_key":"0001130166","primary_entity_name":"Bio Green Med Solution, Inc."},"word_count":54,"has_tables":true,"body_markdown":"Item 7, of our Annual Report on Form 10-K for the year ended December 31, 2025 and Note 2 to our unaudited consolidated financial statements\nincluded elsewhere in this Quarterly Report on Form 10-Q. There have been no material changes to our critical accounting policies during\nthe three months ended March 31, 2026.\n\n \n\n23"}